| |
Group A |
Group B |
Group C |
p |
| Number |
31 |
25 |
11 |
|
| Patient survival (%) |
93.5 |
92.0 |
90.9 |
0.450 |
| Death-uncensored graft survival (%) |
64.5 |
76.0 |
90.9 |
0.869 |
| Death-censored graft survival (%) |
58.1 |
68.0 |
81.8 |
0.997 |
| Acute rejection within 12 months after transplantation (%) |
35.5 |
36.0 |
9.1 |
0.221 |
| Cytomegalovirus infection within 12 months after transplantation (%) |
22.6 |
8.0 |
27.3 |
0.263 |
| eGFR 1 year after transplantation, mean ± SD (mL/min/1.73 m2) |
40.7 ± 9.4 |
41.0 ± 10.7 |
51.4 ± 14.3 |
0.025 |
| δeGFR, mean ± SD (mL/min/1.73 m2) |
31.6 ± 10.0 |
29.5 ± 15.1 |
25.4 ± 16.0 |
0.450 |
